Indefinite Delivery Contract SPE2DU25D5105

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D3941, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a $999,999,999 contract to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $4,999,999, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard,...
The Indefinite Delivery Contract (IDC) SPE2DU25D1008 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The solicitation for this IDC, referred to as the Pharmaceutical...
This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion. It was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD)...
The Indefinite Delivery Contract (IDC) SPE2DR25D3301 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $9,999,999,999. The contract is intended to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency (DHA),...
The Indefinite Delivery Contract (IDC) SPE2DR25D3404 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 contract, which has a period of performance through December 2036, serves as a primary vehicle for the government to procure critical medical commodities including...
The Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and Naval Fleet. This unrestricted, single-award contract has an estimated total value of $30.3 billion over a 30-month base period...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The IDC will establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V...

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999.00, will provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet, through the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The contract covers a broad range of pharmaceutical and medical products, including brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and test kits, across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The IDC has a base period of 30 months and three 30-month option periods, with an estimated total value of $30.3 billion for the entire program. The contract is a firm-fixed price, requirements-type contract awarded on a lowest price technically acceptable (LPTA) basis, with the intention to make multiple awards for separate regions to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.

The original solicitation, which is expected to be issued in March 2024, will be open for 45 days and is an unrestricted, fully competitive acquisition. The DLA Troop Support Medical Supply Chain is planning to establish Prime Vendor Contracts for the PPV-G program to provide worldwide pharmaceutical support to its various customers. The contracts will cover normal day-to-day operations, planned and unplanned contingency, Prime Vendor Readiness, and War Readiness Materiel support to both CONUS and OCONUS locations. The Government intends to make multiple primary supplier awards for the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet (CONUS/OCONUS) line items, as well as one award for the Back-Up supplier (all regions) line items, ensuring at least three different contractors are awarded under this solicitation.

Generated 6/6/25, 9:49 AM